Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
1.360
+0.060 (+4.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
36
37
Next >
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
↗
September 20, 2022
Gainers
Via
Benzinga
Why Ocugen Shares Are Diving
↗
September 19, 2022
Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 4.15% to $2.08 Monday morning. Shares of several vaccine companies at large are trading lower possibly after President Biden in a '60 Minutes'...
Via
Benzinga
MarketBeat: Week in Review 8/22 - 8/26
August 27, 2022
The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week
Via
MarketBeat
Topics
Economy
Are Ocugen or Amarin Good Penny Stocks to Buy?
August 24, 2022
This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing.
Via
MarketBeat
Where Ocugen Stands With Analysts
↗
August 23, 2022
Analysts have provided the following ratings for Ocugen (NASDAQ:OCGN) within the last quarter:
Via
Benzinga
This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
↗
August 23, 2022
Via
Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
↗
September 06, 2022
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Via
Benzinga
Indonesia Energy (INDO) Stock Soars as Natural Gas Prices Spike
↗
August 23, 2022
Indonesia Energy (INDO) stock is rising higher on Tuesday alongside the increasing price of natural gas as Europe seeks new fuel sources.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
↗
August 23, 2022
Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company's shares.
Via
InvestorPlace
Ocugen's Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years
↗
June 21, 2022
Via
Benzinga
Ocugen Diversifies Its Pipeline With New Cell Therapy Platform
↗
May 24, 2022
Via
Benzinga
OCGN Stock Falls Despite Positive FDA Update
↗
May 23, 2022
Shares of the biotech company are falling despite news that the FDA has cleared it to resume clinical trials of its Covid-19 vaccine.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022
↗
August 23, 2022
Via
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
↗
August 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Outlook For Ocugen
↗
August 04, 2022
Ocugen (NASDAQ:OCGN) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Ocugen will report an...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
July 15, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial
↗
May 23, 2022
Via
Benzinga
The Top Reasons to Avoid the Ocugen Stock
↗
April 28, 2022
WIth Ocugen, there’s nothing to get excited about here. Avoid the OCGN stock, as it heads significantly lower.
Via
InvestorPlace
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
↗
April 25, 2022
Via
Benzinga
Earnings Scheduled For August 5, 2022
↗
August 05, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Via
Benzinga
Why Ocugen Shares Are Trading Higher Today
↗
April 18, 2022
Via
Benzinga
Why Is Ocugen (OCGN) Stock Down Today?
↗
April 12, 2022
Shares of OCGN stock are trading lower after the FDA announced that it had placed a clinical hold on Covaxin. Here's what you should know.
Via
InvestorPlace
FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial
↗
April 12, 2022
The
Via
Benzinga
Here's Why Ocugen Shares Are Falling
↗
April 12, 2022
Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 5.86% to $2.73 during Tuesday's pre-market session after the company announced that it was informed by the FDA that...
Via
Benzinga
7 Stocks to Short Before July 2022
↗
June 15, 2022
There are many highly overvalued publicly traded companies that will have trouble staying afloat, giving investors many stocks to short.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022
↗
June 02, 2022
Via
Benzinga
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
↗
April 22, 2022
While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium.
Via
InvestorPlace
State Street Just Bought Ocugen (OCGN) Stock. Here’s Why.
↗
April 14, 2022
OCGN stock has declined by over 90% in the past five years. However, that hasn't stopped State Street from more than doubling its position.
Via
InvestorPlace
Earnings Scheduled For May 6, 2022
↗
May 06, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Via
Benzinga
Why Is Lixte Biotechnology (LIXT) Stock Up Today?
↗
April 12, 2022
Lixte Biotechnology (LIXT) stock is rocketing higher on Tuesday after the company revealed pre-clinical results for one of its treatments.
Via
InvestorPlace
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
